China’s Biotech Revolution: Innovation and Global Impact

About this session

China’s biotech sector is undergoing a transformative evolution, positioning itself as a global leader in drug development and innovation. This session will delve into the latest breakthroughs within China’s vibrant R&D ecosystem, from cutting-edge therapeutics to advancements in AI-powered drug discovery. Panellists will discuss how regulatory reforms, strategic investments, and cross-border partnerships are driving China’s rapid progress and reshaping the global biotech landscape.

Speakers

• 

  Philip Coxon

  Executive Director, Business Development · Insmed

  Moderator

• AH

  Alicia Hong

  VP, Business Development Asia · BioNTech SE

  Panelist

• XQ

  Xueming Qian

  Chairman & CEO · Transcenta

  Panelist

• JZ

  Jia Zhuang

  Executive Director · ATLATL Ventures

  Panelist